CBUS Earnings — Cibus, Inc. Class A Common Stock Post-ER Performance | BigEarnings
CBUS — Cibus, Inc. Class A Common Stock
XNAS · Healthcare · Biotechnology
Price—
Market Cap$109.9M
P/E—
52W Range— – —
Next Earnings2026-08-13
About Cibus, Inc. Class A Common Stock
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
